The Biotechnology Industry Organization (BIO) will take the wraps off some findings from a report on the role of Intellectual Property Rights (IPRs) in encouraging upstream R&D and downstream commercialization in biotechnology at the 2012 BIO International Convention in Boston.
“Taking Stock: the Gains of Global Biotechnology Research from IPRs”
The report, titled “Taking Stock: the Gains of Global Biotechnology Research from IPRs,” will bring together experts to discuss how IPRs have affected innovation and the development of new biotechnologies and whether they contribute to growth in partnerships and other models of collaboration between biotechnology R&D actors such as universities, small and medium sized entities (SMEs) and pharmaceutical manufacturers.
The session will unveil a new report, titled “Taking Stock: the Gains of Global Biotechnology Research from IPRs,” which focuses on the extent to which intellectual property rights play a role in encouraging upstream R&D and downstream commercialization in biotechnology in developed and developing countries.
BIO International Convention, Boston Convention & Exhibition Center, Room 259A
Tuesday, June 19, 2:00 pm – 3:30 pm
This report will highlight the need for intellectual property rights and the importance for developing countries to advance in the biotechnology field. In order for countries to build a strong and thriving biotech sector, strong intellectual property protection is a must.